Annotation Detail for GDE1
Basic Information
Top
Pathway ID | Pathway Name |
---|
PWY0-381 | glycerol degradation I |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of GDE1 mRNA | decreases expression | 20018196
|
C010176 |
halofuginone |
halofuginone results in decreased expression of GDE1 mRNA | decreases expression | 17180598
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of GDE1 mRNA | increases expression | 12832660
|
D013752 |
Tetracycline |
Tetracycline results in decreased expression of GDE1 mRNA | decreases expression | 16917069
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.58 | 18653653 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
4.11 | 16434500 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.57 | 19483382 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.98 | 20889678 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
3.12 | 19176532 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.57 | 18249437 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetracycline |
3.00 | 17522070 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.90 | 12083418 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.15 | 20426865 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
9.44 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Tetracycline |
9.44 | 16917069 19224547 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.76 | 20558911 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.55 | 19176532 19772884 16221962 18467677 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.58 | 20558911 |
MESH:D006965 |
Hyperplasia |
|
halofuginone |
5.81 | 11874485 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.87 | 16306350 |
MESH:D008103 |
Liver Cirrhosis |
|
halofuginone |
4.22 | 17180598 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
halofuginone |
2.86 | 16489207 18458672 14739098 11172339 12175628 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.86 | 15474484 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
1.93 | 20007298 16377806 15890375 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
4.07 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.27 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.25 | 16411023 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
2.11 | 17405874 |
MESH:D009395 |
Nephritis, Interstitial |
|
Tetracycline |
5.51 | 9884423 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.88 | 20558911 |
MESH:D010391 |
Pemphigoid, Bullous |
|
Tetracycline |
6.16 | 11026799 |
MESH:D017096 |
Prion Diseases |
|
Tetracycline |
6.04 | 10903871 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.55 | 19058328 |
MESH:D012871 |
Skin Diseases |
|
halofuginone |
3.59 | 11874485 |
PharmGKB Accession:PA128394662
Releated disease ID |
Related disease Name |
PA446155 | Precursor Cell Lymphoblastic Leukemia-Lymphoma |